(Q44863693)

English

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

scientific article published in September 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

author name string

Wenzel SE

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Schwartz LB

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Langmack EL

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Halliday JL

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Trudeau JB

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Gibbs RL

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Chu HW

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

160

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1001-1008

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Pathological changes according to the severity of asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Airway inflammation in mild intermittent and in persistent asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Cytokines in symptomatic asthma airways

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Airways inflammation in nocturnal asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.3.9812110

21 January 2018

Identifiers

10.1164/AJRCCM.160.3.9812110

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44863693&oldid=2054241175"